Latest news
COLL Q2 Deep Dive: ADHD Expansion and Pain Business Headwinds Shape Guidance - StockStoryStockStory · Fri, 07 Aug 2026 09:20:45 GMTHAE Q2 Deep Dive: Plasma and Interventional Growth Drive Outperformance, Margin Outlook Steady - StockStoryStockStory · Fri, 07 Aug 2026 09:19:06 GMTCWST Q2 Deep Dive: Acquisition Integration and Pricing Execution Drive Growth Amid Cost Headwinds - StockStoryStockStory · Fri, 07 Aug 2026 07:00:00 GMTWTS Q2 Deep Dive: Data Center Expansion and Product Mix Drive Outperformance - StockStoryStockStory · Thu, 06 Aug 2026 20:02:23 GMTCollegium Pharmaceutical (NASDAQ:COLL) Reports Sales Below Analyst Estimates In Q2 CY2026 Earnings, Stock Drops - StockStoryStockStory · Thu, 06 Aug 2026 12:49:25 GMTCollegium Pharmaceutical (COLL) Reports Earnings Tomorrow: What To Expect - The Globe and MailThe Globe and Mail · Wed, 05 Aug 2026 03:36:00 GMTThe 5 Most Interesting Analyst Questions From Waste Management’s Q2 Earnings Call - TradingViewTradingView · Tue, 04 Aug 2026 05:37:17 GMT2 Unpopular Stocks That Deserve Some Love and 1 Facing Headwinds - StockStoryStockStory · Mon, 03 Aug 2026 08:23:37 GMT